載入...
NOVEL THERAPIES FOR FSGS: PRECLINICAL AND CLINICAL STUDIES
Focal segmental glomerulosclerosis (FSGS) is a rare but important cause of end stage kidney disease in children and adults. Current therapy, consisting of corticosteroids and calcineurin inhibitors, fails to achieve a sustained remission in the majority of patients. Therefore there is a pressing nee...
Na minha lista:
| 發表在: | Adv Chronic Kidney Dis |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409581/ https://ncbi.nlm.nih.gov/pubmed/25704355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ackd.2014.10.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|